Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $80.84 Analyst target: $125.75 Upside: 55.55%
Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. The company is headquartered in Watertown, Massachusetts.
See the full interactive analysis & chart →Informational only — not investment advice.